Outcome of inflammatory bowel disease patients with prior malignancy

BACKGROUND: Inflammatory bowel disease (IBD) treatment options, such as anti-tumor necrosis factor (TNF) agents and thiopurines, are associated with an increased risk of certain malignancies. However, the management of IBD patients with prior malignancy is not well defined and the literature is scar...

Descripción completa

Detalles Bibliográficos
Autores principales: Shani, Uria, Klang, Eyal, Lassman, Simon, Ungar, Bella, Ben-Horin, Shomron, Kopylov, Uri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304530/
https://www.ncbi.nlm.nih.gov/pubmed/37396000
http://dx.doi.org/10.20524/aog.2023.0803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304530/
https://www.ncbi.nlm.nih.gov/pubmed/37396000
http://dx.doi.org/10.20524/aog.2023.0803

Ejemplares similares